Intelligence for human health.

Edwin BioTech brings AI-native discovery and wearable health technologies together to advance research and human wellness.

New targets.
New possibilities.

We use advanced AI models to surface and prioritize research hypotheses in oncology and metabolic health.

Oncology

Investigating cancer biology to identify potential targets for future therapies.

Diabetes

Studying the mechanisms that shape glucose regulation and metabolic health.

Insulin resistance

Exploring why tissues respond less effectively to insulin and where interventions might help.

From discovery
to daily life.

We are developing two complementary capabilities: AI-native research for target discovery and wearable technologies for everyday wellness.

  • AI-native discovery

    Foundation models and computational analysis to prioritize targets for further study.

  • Wearable health

    Exploring how signals from everyday wearables can support personal wellness and decentralized clinical research.

Concept illustration of a graphite wearable ring with optical sensors.

Global trials,
closer to home.

We’re developing a decentralized clinical trial (DCT) product on our Digital Health platform. It’s designed to connect participants, local study teams, and sponsors across countries, so selected study activities can happen outside a central site.

Discuss a DCT partnership
A wearable ring beside a glass globe with connected points, illustrating remote data collection and cross-border trial coordination.

Designed around the study protocol

  • Remote participation

    Virtual check-ins and participant-reported outcomes, with local or in-person visits when the study calls for them.

  • Wearable data collection

    Remote collection of study measures using devices and schedules selected for the protocol.

  • Multi-country coordination

    A shared view of study activities and data completeness for sponsors and participating site teams.

One global
research team.

Headquartered in San Francisco, with research teams across North America, Europe and Asia.

Build what’s next in health.

We welcome collaborations with biopharma and technology teams to advance AI-enabled discovery and shape the future of health management and care.

bd@edwinbio.com

Research / 01

Oncology

Our oncology research uses AI to connect evidence across molecular datasets and published studies. The goal is to identify dependencies worth investigating and better understand why tumors can respond differently to treatment.

Predicted targets are research hypotheses and require experimental validation.

Research / 02

Diabetes

We use computational models to investigate the pathways involved in glucose regulation and metabolic dysfunction. This work aims to help research teams choose which biological questions to pursue in experiments.

Predicted targets are research hypotheses and require experimental validation.

Research / 03

Insulin resistance

We explore how patterns in molecular and metabolic data can point to pathways involved in reduced insulin sensitivity. Our goal is to prioritize questions about how these pathways differ across tissues.

Predicted targets are research hypotheses and require experimental validation.

Partnerships

Start a conversation.

Download a brief to share with bd@edwinbio.com. This site does not send or store your information. Do not include personal health information.